Literature DB >> 8735599

The H295R human adrenocortical cell line contains functional atrial natriuretic peptide receptors that inhibit aldosterone biosynthesis.

V Bodart1, W E Rainey, A Fournier, H Ong, A De Léan.   

Abstract

The inhibitory effect of atrial natriuretic peptide (ANP) on angiotensin II (AII)-stimulated aldosterone secretion has been previously studied in rat and bovine adrenal zona glomerulosa cells in primary culture. However the understanding of the mode of action of ANP at the molecular level has been hampered by limitations of those primary cell culture systems and by the lack of cell lines from human adrenal cortex. Here we demonstrate the presence of fully functional ANP receptors in the recently characterized AII-responsive adrenocortical carcinoma cell line H295R. Specific saturable binding of 125I-rANP to H295R cell membrane preparations revealed a single class of high affinity binding sites with a density of 20 fmol/mg of protein. The pharmacological profile of this ANP receptor was documented by competitive binding of 125I-rANP with naturally occurring natriuretic peptides. rANP was the most potent with a Kd of 42 pM. pBNP32 was less potent with a Kd of 174 pM. 125I-rANP binding was not competed by pCNP (NPRB-specific ligand) nor by C-ANF (NPRC-specific ligand). Photoaffinity labeling of membrane preparations with 125I-BPA-ANP revealed a single specific protein of molecular weight around 130 kDa. This protein was further identified by immunodetection with a specific antibody directed to the human ANP-specific receptor NPRA. Natriuretic peptides stimulated cGMP production by the receptor-coupled guanylate cyclase with the same specificity. Aldosterone production by AII-stimulated H295R cells was dose-dependently inhibited by rANP with an ED50 of 1.5 nM. In addition, we used this model to test two chimeric analogs of ANP and BNP. pBNP1 and pBNP3 were, respectively, 4- and 2-fold more potent than rANP in competing for 125I-rANP binding with Kd of 10 and 20 pM. pBNP1 was 24-fold more potent in inhibiting AII-stimulated aldosterone production with ED50 of 63 pM. pBNP1 is therefore the most potent natriuretic peptide analog tested. In summary, the human H295R cell line contains NPRA receptors positively coupled to the particulate guanylate cyclase and that antagonize angiotensin II stimulation of aldosterone secretion.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8735599     DOI: 10.1016/0303-7207(96)03776-8

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  7 in total

Review 1.  Ultracytochemistry as a tool for the study of the cellular and subcellular localization of membrane-bound guanylate cyclase (GC) activity. Applicability to both receptor-activated and receptor-independent GC activity.

Authors:  Maria Grazia Rambotti; Antonio Spreca; Ileana Giambanco; Guglielmo Sorci; Rosario Donato
Journal:  Mol Cell Biochem       Date:  2002-01       Impact factor: 3.396

2.  Phorbol ester increases mitochondrial cholesterol content in NCI H295R cells.

Authors:  Wendy B Bollag; Patricia Kent; Stephanie White; Mariya V Wilson; Carlos M Isales; Roberto A Calle
Journal:  Mol Cell Endocrinol       Date:  2008-08-28       Impact factor: 4.102

3.  Comparative binding study of rat natriuretic peptide receptor-A.

Authors:  M Marquis; R Fenrick; L Pedro; M Bouvier; A De Léan
Journal:  Mol Cell Biochem       Date:  1999-04       Impact factor: 3.396

4.  Natriuretic peptides receptors in human aldosterone-secreting adenomas.

Authors:  R Sarzani; G Opocher; M V Paci; A S Belloni; F Mantero; P Dessì-Fulgheri; A Rappelli
Journal:  J Endocrinol Invest       Date:  1999 Jul-Aug       Impact factor: 4.256

Review 5.  The Biology of Normal Zona Glomerulosa and Aldosterone-Producing Adenoma: Pathological Implications.

Authors:  Teresa M Seccia; Brasilina Caroccia; Elise P Gomez-Sanchez; Celso E Gomez-Sanchez; Gian Paolo Rossi
Journal:  Endocr Rev       Date:  2018-12-01       Impact factor: 19.871

Review 6.  Protection of kidney function and tissue integrity by pharmacologic use of natriuretic peptides and neprilysin inhibitors.

Authors:  Juan Brignone; Kasper Bostlund Assersen; Mia Jensen; Boye L Jensen; Brian Kloster; Morten Jønler; Lars Lund
Journal:  Pflugers Arch       Date:  2021-04-12       Impact factor: 3.657

7.  Inhibition of endogenous ouabain by atrial natriuretic peptide is a guanylyl cyclase independent effect.

Authors:  Gulay Tegin; Yonglin Gao; John M Hamlyn; Barbara J Clark; Rif S El-Mallakh
Journal:  PLoS One       Date:  2021-11-18       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.